rss Posted December 20, 2018 Report Share Posted December 20, 2018 Related Articles Fluorescent light energy: Treating rosacea subtypes 1, 2, and 3. Clin Case Rep. 2018 Dec;6(12):2385-2390 Authors: Sannino M, Lodi G, Dethlefsen MW, Nisticò SP, Cannarozzo G, Nielsen MCE Abstract Kleresca® biophotonic platform utilizing fluorescent light energy effectively decreased the inflammatory and erythematous reaction common in rosacea subtypes 1, 2, and 3. Kleresca® may be considered as a single treatment for rosacea, targeting multiple features, or combined with invasive methods for an enhanced normalizing and healing profile of the skin. PMID: 30564333 [PubMed] {url} = URL to article Link to comment Share on other sites More sharing options...
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now